Evidence map›Paper›PMID 38457040›Full record

ReviewNaunyn-Schmiedeberg's archives of pharmacology2024

A mechanistic review of the pharmacological potential of narirutin: a dietary flavonoid.

Pratibha Pandey, Fahad Khan, Seema Ramniwas, Mohd Saeed, Irfan Ahmad

Abstract readReview
PubMed Publisher
In one paragraph

Review in Naunyn-Schmiedeberg's archives of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Therapeutic Potential of Plant Phenolic Acids Combating Cancer Drug Resistance.Recent advances in food, nutrition & agriculture · 2026
    Review
  2. Phytochemical analysis ofOpen life sciences · 2025
    Article
  3. Narirutin-Rich Celluclast Extract from Mandarin (International journal of molecular sciences · 2024
    Article
  4. Special Issue: "Recent Advances in Ion Channels and Ion Channelopathies".International journal of molecular sciences · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pratibha PandeyUniversity Centre for Research and Development, University Institute of Biotechnology, Chandigarh University, Gharuan, Mohali, Punjab, India.
Fahad KhanCenter for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India. fahadintegralian@gmail.com.
Seema RamniwasUniversity Centre for Research and Development, University Institute of Biotechnology, Chandigarh University, Gharuan, Mohali, Punjab, India.
Mohd SaeedDepartment of Biology, College of Science, University of Hail, Hail, Saudi Arabia.
Irfan AhmadDepartment of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid University, Abha, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Flavanones, a type of polyphenol, are found in substantial amounts in citrus fruits. When high- or moderate-dose orange juice consumption occurs, flavanones make up a significant portion of the total polyphenols in plasma. Disaccharide derivative narirutin, mainly dihydroxy flavanone, is found in citrus fruits. The substantial chemotherapeutic potential of narirutin has been amply demonstrated by numerous experimental studies. Consequently, the purpose of this study is to compile the research that has already been done showing narirutin to be a promising anticancer drug, with its mechanism of action being documented in treatment plans for various cancer forms. Narirutin functions in a variety of cancer cells by regulating several pathways that include cell cycle arrest, apoptosis, antiangiogenic, antimetastatic, and DNA repair. Narirutin has been shown to modify many molecular targets linked to the development of cancer, including drug transporters, cell cycle mediators, transcription factors, reactive oxygen species, reactive nitrogen species, and inflammatory cytokines. Taken together, these reviews offer important new information about narirutin's potential as a potent and promising drug candidate for use in medicines, functional foods, dietary supplements, nutraceuticals, and other products targeted at improving the treatment of cancer.

Indexed as

NeoplasmsAnimalsAntineoplastic AgentsAntineoplastic Agents, PhytogenicDisaccharidesFlavanonesFlavonoidsHumansHydroxyethylrutosideAntineoplastic AgentsAntineoplastic Agents, PhytogenicDisaccharidesFlavanonesFlavonoidsHydroxyethylrutosidenarirutinAnticancer potentialCitrusMetabolismNarirutinPhytocompound

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.